GSK (GSK) is pushing the UK government to give pharmaceutical companies more access to its public health data in order to accelerate drug ...

GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...

Vertex Pharmaceuticals (VRTX) closed at $502.55 in the latest trading session, marking a +0.45% move from the prior day.

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, representing a 462% increase over prior yearAdjusted EBITDA in ...

India-UK Trade Talks Heat Up Over Trump’s Reciprocal Tariff Threat | Stock Market Moves to Watch As U.S. President Donald Trump’s reciprocal tariffs loom large, set to take effect on April 2, 2025, ...

The tariffs will apply to fully assembled cars as well as key auto parts including engines, transmissions and electrical ...

Alvotech (NASDAQ: ALVO, or the "Company”), a global biotech company specializing in the development and manufacture of ...

Our writer’s been crunching the numbers to see which FTSE 100 stock was the winner from the Chancellor’s speech in Parliament yesterday. The post The FTSE 100 winner from yesterday’s UK spring ...

The developer of a nasal spray-mist erectile dysfunction (ED) treatment, LTR Pharma (ASX:LTP) has revealed a new product – ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

The FTSE 100 is up 0.4 per cent while shares in Paris are up 0.75 per cent. The Dax started very brightly but pared back some gains, likely on tariff concerns, although it’s still up 0.5 per cent.

Tokyo, Japan and Cambridge, UK, 25 March 2025 - Nxera Pharma Co., Ltd. ("Nxera" or "the Company"; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a pot ...